Technical Analysis for CALT - Calliditas Therapeutics AB

Grade Last Price % Change Price Change
F 27.5 0.00% 0.00
CALT closed unchanged on Friday, April 9, 2021, on 1.94 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CALT trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness 2.57%
200 DMA Resistance Bearish 0.00%
Older End-of-Day Signals for CALT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Calliditas Therapeutics AB Description

Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmaceutical Industry Pharmaceutical Products Pharmacy Health Sciences Medication Kidney Disease Kidney Diseases Renal Disease Iga Nephropathy Pharmaceutics

Is CALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 38.0
52 Week Low 19.0
Average Volume 35,074
200-Day Moving Average 27.66
50-Day Moving Average 29.11
20-Day Moving Average 28.52
10-Day Moving Average 27.66
Average True Range 0.92
ADX 22.83
+DI 15.45
-DI 31.29
Chandelier Exit (Long, 3 ATRs ) 27.43
Chandelier Exit (Short, 3 ATRs ) 29.55
Upper Bollinger Band 30.63
Lower Bollinger Band 26.41
Percent B (%b) 0.26
BandWidth 14.82
MACD Line -0.60
MACD Signal Line -0.52
MACD Histogram -0.0823
Fundamentals Value
Market Cap 686.7 Million
Num Shares 25 Million
EPS -1.19
Price-to-Earnings (P/E) Ratio -23.04
Price-to-Sales 239.56
Price-to-Book 5.18
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.97
Resistance 3 (R3) 27.92 27.71 27.89
Resistance 2 (R2) 27.71 27.59 27.74 27.86
Resistance 1 (R1) 27.61 27.52 27.66 27.66 27.84
Pivot Point 27.40 27.40 27.43 27.43 27.40
Support 1 (S1) 27.30 27.28 27.35 27.35 27.16
Support 2 (S2) 27.09 27.21 27.12 27.14
Support 3 (S3) 26.99 27.09 27.11
Support 4 (S4) 27.04